326 related articles for article (PubMed ID: 10469082)
1. Amelanotic lentigo maligna melanoma: a unique case presentation.
Conrad N; Jackson B; Goldberg L
Dermatol Surg; 1999 May; 25(5):408-11. PubMed ID: 10469082
[TBL] [Abstract][Full Text] [Related]
2. Histologic predictors of invasion in partially biopsied lentigo maligna melanoma.
Aouidad I; Fargeas C; Romero P; Sei JF; Chaussade V; Beauchet A; Clerici T; Zimmermann U; Saiag P; Funck-Brentano E
J Am Acad Dermatol; 2019 Apr; 80(4):1150-1152. PubMed ID: 30879481
[No Abstract] [Full Text] [Related]
3. Amelanotic lentigo maligna and amelanotic lentigo maligna melanoma: a report of three cases mimicking intraepidermal squamous carcinoma.
Allan SJ; Dicker AJ; Tidman MJ; McLaren KM; Hunter JA
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):78-81. PubMed ID: 9731974
[TBL] [Abstract][Full Text] [Related]
4. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections.
Stonecipher MR; Leshin B; Patrick J; White WL
J Am Acad Dermatol; 1993 Oct; 29(4):589-94. PubMed ID: 8408795
[TBL] [Abstract][Full Text] [Related]
5. Management of lentigo maligna and lentigo maligna melanoma: seminars in surgical oncology.
Arlette JP; Trotter MJ; Trotter T; Temple CL
J Surg Oncol; 2004 Jul; 86(4):179-86. PubMed ID: 15221924
[TBL] [Abstract][Full Text] [Related]
6. Nine per cent of biopsy-proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery.
Zoutendijk J; Tio D; Koljenovic S; van den Bos RR
Br J Dermatol; 2019 Aug; 181(2):383-384. PubMed ID: 30716164
[No Abstract] [Full Text] [Related]
7. Treatment of lentigo maligna.
Carucci JA
Cutis; 2001 May; 67(5):389-92. PubMed ID: 11381854
[TBL] [Abstract][Full Text] [Related]
8. Lentigo maligna of the cheek: discussion of surgical treatment options.
Ratner D
Skinmed; 2002; 1(2):144-6. PubMed ID: 14673342
[No Abstract] [Full Text] [Related]
9. Amelanotic malignant melanoma following cryosurgery for atypical lentigo maligna.
McKenna DB; Cooper EJ; Kavanagh GM; Davie RM; McLaren KM; Tidman MJ
Clin Exp Dermatol; 2000 Nov; 25(8):600-4. PubMed ID: 11167970
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of lentigo maligna and lentigo maligna melanoma with Mohs' micrographic surgery aided by rush permanent sections.
Cohen LM; McCall MW; Hodge SJ; Freedman JD; Callen JP; Zax RH
Cancer; 1994 Jun; 73(12):2964-70. PubMed ID: 8199993
[TBL] [Abstract][Full Text] [Related]
11. Immunostained Frozen Sections Vs Traditional Permanent Paraffin Sections for Lentigo Maligna Treated With Mohs Micrographic Surgery.
Punchihewa N; Odhavji S; Upjohn E; Bekhor P
Dermatol Surg; 2022 Jan; 48(1):43-46. PubMed ID: 34772830
[TBL] [Abstract][Full Text] [Related]
12. Amelanotic lentigo maligna melanoma.
Kaufmann R; Nikelski K; Weber L; Sterry W
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):339-42. PubMed ID: 7829736
[TBL] [Abstract][Full Text] [Related]
13. Comparison of surgical margins for lentigo maligna versus melanoma in situ.
Kunishige JH; Doan L; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2019 Jul; 81(1):204-212. PubMed ID: 31014825
[TBL] [Abstract][Full Text] [Related]
14. Lentigo maligna and lentigo maligna melanoma.
Johr RH; Stolz W
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):512. PubMed ID: 9308580
[No Abstract] [Full Text] [Related]
15. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1.
Kelley LC; Starkus L
J Am Acad Dermatol; 2002 Jan; 46(1):78-84. PubMed ID: 11756950
[TBL] [Abstract][Full Text] [Related]
16. Lentigo maligna and lentigo maligna melanoma.
Cohen LM
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):913. PubMed ID: 9204053
[No Abstract] [Full Text] [Related]
17. Management of lentigo maligna and lentigo maligna melanoma with tangential paraffin-embedded sections.
Cohen LM
J Am Acad Dermatol; 1994 Oct; 31(4):691-2. PubMed ID: 8089308
[No Abstract] [Full Text] [Related]
18. Re: ultraviolet-assisted punch biopsy mapping for lentigo maligna melanoma.
Moody BR; Sengelmann RD
Ann Plast Surg; 2002 Sep; 49(3):333. PubMed ID: 12351987
[No Abstract] [Full Text] [Related]
19. Margin control for lentigo maligna.
Robinson JK
J Am Acad Dermatol; 1994 Jul; 31(1):79-85. PubMed ID: 8021377
[TBL] [Abstract][Full Text] [Related]
20. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
Magro CM; Yang SE; Zippin JH; Zembowicz A
Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
